Search
CVT-6883
go.drugbank.com/drugs/DB05936ExperimentalCVT-6883 is a selective, potent and orally available A2B-adenosine receptor antagonist which CV Therapeutics is investigating for the potential treatment of asthma and other conditions related to inflammation
ARCoV
go.drugbank.com/drugs/DB15855ExperimentalAs of July 2020, the vaccine candidate is set for Phase 1 clinical trials to investigate for safety, tolerance, and immunogenicity (ChiCTR2000034112). … Manufactured as a liquid, ARCoV is thermostable at room temperature for at least 1 week.
Dilmapimod
go.drugbank.com/drugs/DB12140InvestigationalMethotrexate (common treatment for RA patients) also has potential liver toxicity.}
Sulfamazone
go.drugbank.com/drugs/DB13556ExperimentalCategories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseINCB7839
go.drugbank.com/drugs/DB05033InvestigationalINCB7839 is a novel, orally available ADAM metalloprotease inhibitor that is designed to block activation of the epidermal growth factor (EGFR) pathways. It represents a potentially important new class of targeted breast cancer therapy. ...
Bertilimumab
go.drugbank.com/drugs/DB05429InvestigationalIt is developed by MedImmune for the treatment of Allergic Rhinitis.
Lysergic acid diethylamide
go.drugbank.com/drugs/DB04829IllicitInvestigationalExplanations in terms of LSD physically remaining in the body for months or years after consumption have been discounted by experimental evidence.
Categories: Heterocyclic Compounds with 4 or More RingsOcaratuzumab
go.drugbank.com/drugs/DB17359InvestigationalIt is being investigated for cancers and autoimmune disorders.
ISP-001
go.drugbank.com/drugs/DB18501InvestigationalISP-001 consists of sleeping beauty transposon-engineered autologous plasmablasts for expression and delivery of alpha-L-iduronidase.
Pyrrolidone
go.drugbank.com/drugs/DB19152ExperimentalPyrrolidone is under investigation in clinical trial NCT05444998 (Neoadjuvant Inituomab, Pyrrolidone and Nab-paclitaxel for Her2+breast Cancer).